Polycystic ovary syndrome overdiagnosis claim "not based on evidence", say experts

Melanie Gibson-Helm, Veryan McAllister, Robert J. Norman, Helena J Teede

Research output: Contribution to specialist publicationLetterOther

Abstract

A RECENT commentary by Australian authors, published in the BMJ, which proposed overdiagnosis of polycystic ovary syndrome (PCOS), drew on very limited evidence and did not engage affected women.

Along with related media attention, the BMJ article arguably adds unnecessary confusion to a field in which researchers, clinicians and patient advocacy groups have worked together internationally to deliver constructive, evidence-based messages aiming to provide clarity for women with PCOS and their health care providers. We have brought together patient advocates, health care providers and academics to counter this largely non-evidence based perspective, drawing on evidence regarding PCOS prevalence, diagnosis, complications and distress. We also outline how improvement in health care and support for women with PCOS will be aided by initiatives to develop the first international evidence-based guideline and comprehensive knowledge translation program for PCOS.
Original languageEnglish
Volume2017
No.35
Specialist publicationMJA Insight
Publication statusPublished - 11 Sep 2017

Cite this